1.A Case of Herpes Zoster Oticus Involving Vestibular Nerve without Facial Nerve Palsy .
Sung Hyun BOO ; Kwon Hyo BOK ; Nam Gyu RYU ; Won Ho CHUNG
Journal of the Korean Balance Society 2006;5(2):311-316
Herpes zoster oticus (Ramsay Hunt syndrome) is characterized by facial nerve paralysis associated with vesticular eruptions and cochleovestibular symptoms. Many evidences have supported that it is caused by the reactivation of latent varicella-zoster virus in the geniculate ganglion. Recently we experienced a case 49-year-old man presented severe vertigo and a vesicular eruptions of auricle and external ear canal. It is an unusual variant of herpes zoster oticus that involves only vestibular nerve without facial nerve palsy and hearing loss. We believe this case results from reactivation of latent varicella zoster virus in the vestibular ganglion and report with a review of literatures.
Dizziness
;
Ear Canal
;
Facial Nerve*
;
Ganglion Cysts
;
Geniculate Ganglion
;
Hearing Loss
;
Herpes Zoster Oticus*
;
Herpes Zoster*
;
Herpesvirus 3, Human
;
Humans
;
Middle Aged
;
Paralysis*
;
Vertigo
;
Vestibular Nerve*
2.Histopathologic Findings of an Unsuccessful Molteno Implant.
Journal of the Korean Ophthalmological Society 1999;40(7):1944-1949
We documented the histopathologic findings of an eye with Molteno implant that was nonfunctional at 3 years after implantation.In 1995,a 62-year-old woman developed neovascular glaucoma in her right eye,and installation of a Molteno implant was performed.However,she was lost to follow-up until 1998,when she presented with a blind eye that have to be enucleated with molteno implant because of painful phthisis bulbi.On external examination the implant plate was located in the superotemporal equatorial region of the globe,8 mmposterior to the limbus and 9 mm anterior to the optic nerve.There were adhesions between the plate and surround-ing fibrous tissue.The drainage tube into the anterior chamber left in situ. On microscopic examination the adjacent bleb wall consisted of multilayer, degenerated collagenous connective tissue,maximal 0.7 mmin thickness.Its inner portion mainly consisted of paucicellular,hyalinized and sclerotic col-lagen fibers and outer portion was relatively fibrovascular tissues with a few vascular endothelial cells and fibroblasts.And,there were chronic lym-phocytic infiltrates around a silicone tube insertion site into the anterior chamber.
Anterior Chamber
;
Blister
;
Collagen
;
Drainage
;
Endothelial Cells
;
Female
;
Glaucoma, Neovascular
;
Humans
;
Lost to Follow-Up
;
Middle Aged
;
Silicones
3.The Effect of Aqueous Humor Suppressants on the Duration of Intravitreal Perfluorocarbon Gas Bubble in Rabbits.
Gyu Won RYU ; Young Il KIM ; Il Han YUN
Journal of the Korean Ophthalmological Society 2001;42(3):507-511
PURPOSE: Although the process by which intravitreal perfluorocarbon gas is absorbed is incompletely understood, it is known that considerable absorption of intravitreal perfluorocarbon gas occurs through the aqueous humor. The aim of the study was to evaluate experimentally the effect of topical aqueous humor suppressants on the intravitreal perfluorocarbon gas bubble duration. METHODS: After sulfur hexafluoride and perfluoropropane were injected intravitreally in ten rabbits, we measured the time of gas bubble disappearance in eyes treated with topical aqueous humor suppressants and in those not treated. RESULTS: The mean time(+/-SD) to disappearance of 0.4 cc of sulfur hexafluoride was 6.0+/-0.71 days, which was prolonged to 8.0+/-0.71 days with topical aqueous humor suppressants. The mean time(+/-SD) to disappearance of 0.2 cc perfluoropropane was 14.8+/-0.84 days, while it was prolonged to 22.0+/-1.58 days with topical aqueous humor suppressants. CONCLUSIONS: Sulfur hexafluoride and perfluoropropane intravitreal gas bubbles last longer in rabbit eyes treated with aqueous humor suppressants than in fellow control eyes.
Absorption
;
Aqueous Humor*
;
Rabbits*
;
Sulfur Hexafluoride
4.Triple detector SPECT imaging with 99mTc-DMSA in adult patients with urinary tract infection.
Jin Sook RYU ; Won Gyu BAE ; Dae Hyuk MOON ; Myung Hae LEE ; Soon Bae KIM ; Su Kil PARK ; Jung Sik PARK ; Changgi D HONG ; Kyung Sik CHO
Korean Journal of Nuclear Medicine 1992;26(2):290-298
No abstract available.
Adult*
;
Humans
;
Technetium Tc 99m Dimercaptosuccinic Acid*
;
Tomography, Emission-Computed, Single-Photon*
;
Urinary Tract Infections*
;
Urinary Tract*
5.Role of Whole Body FDG-PET in the Diagnosis of Hidden Distant Metastasis before Liver Transplantation in Patients with Primary Liver Cancer.
Won Woo LEE ; Jin Sook RYU ; You Jung YANG ; Jae Seung KIM ; Jeong Seok YEO ; Dae Hyuk MOON ; Sung Gyu LEE
Korean Journal of Nuclear Medicine 2002;36(6):368-380
No abstract available.
Diagnosis*
;
Humans
;
Liver Neoplasms*
;
Liver Transplantation*
;
Liver*
;
Neoplasm Metastasis*
6.Role of Whole Body FDG-PET in the Diagnosis of Hidden Distant Metastasis before Liver Transplantation in Patients with Primary Liver Cancer.
Won Woo LEE ; Jin Sook RYU ; You Jung YANG ; Jae Seung KIM ; Jeong Seok YEO ; Dae Hyuk MOON ; Sung Gyu LEE
Korean Journal of Nuclear Medicine 2002;36(6):368-380
No abstract available.
Diagnosis*
;
Humans
;
Liver Neoplasms*
;
Liver Transplantation*
;
Liver*
;
Neoplasm Metastasis*
7.Dehydroepiandrosterone sulphate (DHEAS) levels in premenopausal women with systemic lupus erythematosus.
Jin Hyuk YUN ; Seung Hoon RYU ; Won Tec JUNG ; Sung Won LEE ; Won Suk AN ; Hyuck LEE ; Choon Hee SON ; Seong Eun KIM ; Duk Gyu KIM ; Won Tae CHUNG
The Journal of the Korean Rheumatism Association 2002;9(2):90-96
OBJECTIVE: Dehydroepiandrosterone sulphate (DHEAS), the major steroidal product of the human adrenal, is abnormally low in patients with SLE. Moreover, a recent study confirms a positive effect of the precursor DHEA on the disease course in SLE, which supports an etiologically important role of the hormone on SLE. The aim of this study is to search for an interrelation between clinical manifestations, laboratory findings, and disease activities and DHEAS in patients with SLE. METHOD: DHEAS were measured by radioimmunoassay kit using 125I-labeled DHEA-SO4 antibody-coated tube in the serum of 48 patients with SLE and in 46 control subjects. Laboratory findings, clinical symptoms, signs and SLE disease activity index (SLEDAI) in SLE patients were evaluated at blood sampling time. RESULTS: DHEAS was lower in patients with SLE compared to controls (45.60+/-42.62 mug/dL vs 101.55+/-56.54 mug/dL, p<0.005). The serum DHEAS levels were significantly negative correlation with SLEDAI (r=-0.333, p<0.05). There were significantly negative correlations between daily steroid dose and DHEAS (r=-0.384, p=0.012), and the amount of steroid used during previous 2 months and DHEAS (r=-0.011, p=0.011). CONCLUSIONS: Patients with SLE have low levels of DHEAS and significant negative correlation between SLEDAI, steroid dose and DHEAS.
Dehydroepiandrosterone*
;
Female
;
Humans
;
Lupus Erythematosus, Systemic*
;
Radioimmunoassay
8.The Role of Hepatobiliary Scintigraphy and Oral Cholecystography in Predicting the Performance of Laparoscopic Cholecystectomy.
Dae Hyuk MOON ; Seoung Oh YANG ; Hee Kyung LEE ; Kyoung Sook WON ; Jin Sook RYU ; Dong Bok HAN ; Cheol Min PARK ; Moon Gyu LEE ; Kwang Min PARK ; Sung Gyu LEE
Korean Journal of Nuclear Medicine 1997;31(1):102-107
131I-6beta-iodomethyl-19-norcholesterol(NP-59) has an advantage to assess adrenal dysfunction caused by adrenal cortical disorders. The aim of this study is to evaluate the clinical usefulness of NP-59 scintigraphy in each adrenral disease. Ten patients who did eleven NP-59 adrenal scintigraphies at Dong-A University Hospital from March 1990 to December 1996 were selected as the subject. Among the subject there were 5 cases of Cushing's syndrome, 2 cases of incidentaloma, 1 case of metastatic adrenal tumor, liver cirrhosis with hirsutism and hypertension respectively. Among 5 case of Cushing's syndrome, there were 2 cases of Cushing's disease, 2 cases of adrenal adenoma and 1 case of adrenal carcinoma. There are no disagreement between clinical diagnosis and scan finding in Cushing's syndrome. In 2 incidentaloma cases, even though one is interpretated as a functioning tumor, both of 2 cases could avoid unnecessary biopsy according to scintigraphy result. One case of hirsutism, clinically adrenal originated, revealed the normal scintigraphic hirsutism was extra-adrenal origin. One case of hypertension took the study to exclude the possibility of primary aldosteronism. Normal suppression scan finding revealed that primary aldosteronism did not exist in this case. In conclusion, NP-59 scintigraphy was very useful in diagnosis and differential diagnosis of Cushing's syndrome and it could avoid unnecessary biopsy in the incidental adrenal tumor.
Adenoma
;
Adosterol
;
Biopsy
;
Cholecystectomy, Laparoscopic*
;
Cholecystography*
;
Cushing Syndrome
;
Diagnosis
;
Diagnosis, Differential
;
Hirsutism
;
Humans
;
Hyperaldosteronism
;
Hypertension
;
Liver Cirrhosis
;
Radionuclide Imaging*
9.Percutaneous Closure of an Iatrogenic Ventricular Septal Defect Following Concomitant Septal Myectomy at the Time of Aortic Valve Replacement.
Il Hwan RYU ; Won Ho KIM ; Ah Jeong RYU ; Min Gyu KIM ; Jae Woong JEON ; Joo Seok KIM ; Jae Joon LEE ; Jin Ho CHOI
Korean Circulation Journal 2014;44(1):45-48
A 77-year-old female patient underwent aortic valve replacement (AVR) with concomitant septal myectomy and tricuspid annuloplasty. Her symptoms did not improve after a successful operation. Echocardiogram demonstrated the presence of an iatrogenic ventricular septal defect (VSD). It was muscular in location and not the usual AVR with membraneous type of VSD, suggesting a complication from the myectomy. Percutaneous closure of the VSD remained the only feasible option due to her poor overall medical status. A 14-mm Amplazter VSD occluder was deployed successfully, by means of the trans-septal technique. She has improved very well postoperatively.
Aged
;
Aortic Valve*
;
Female
;
Heart Septal Defects
;
Heart Septal Defects, Ventricular*
;
Humans
;
Septal Occluder Device
10.Cochlear Implantation for Profound Hearing Loss After Multimodal Treatment for Neuroblastoma in Children.
Nam Gyu RYU ; Il Joon MOON ; Young Soo CHANG ; Byoung Kil KIM ; Won Ho CHUNG ; Yang Sun CHO ; Sung Hwa HONG
Clinical and Experimental Otorhinolaryngology 2015;8(4):329-334
OBJECTIVES: Neuroblastoma (NBL) predominantly affects children under 5 years of age. Through multimodal therapy, including chemotherapy, radiotherapy, surgery, and peripheral blood stem cell transplantation, the survival rate in patients with NBL have improved while treatment-related complications have also increased. Treatment-related ototoxicity, mainly from cisplatin, can result in profound hearing loss requiring cochlear implantation (CI). We analyzed the effectiveness and hearing preservation of CI recipients who had treated with multimodal therapy due to NBL. METHODS: Patients who received multimodal therapy for NBL and subsequent CIs were enrolled. A detailed review of the perioperative hearing test, speech evaluation, and posttreatment complications was conducted. Speech performance was analyzed using the category of auditory performance (CAP) score and the postoperative hearing preservation of low frequencies was also compared. Patients who were candidates for electro-acoustic stimulation (EAS) used an EAS electrode for low frequency hearing preservation. RESULTS: Three patients were identified and all patients showed improvement of speech performance after CI. The average of CAP score improved from 4.3 preoperatively to 5.8 at 1 year postoperatively. Two patients who were fitted with the Flex electrode showed complete hearing preservation and the preserved hearing was maintained over 1 year. The one remaining patient was given the standard CI-512 electrode and showed partial hearing preservation. CONCLUSION: Patients with profound hearing loss resulting from NBL multimodal therapy can be good candidates for CI, especially for EAS. A soft surgical technique as well as a specifically designed electrode should be applied to this specific population during the CI operation in order to preserve residual hearing and achieve better outcomes.
Child*
;
Cisplatin
;
Cochlear Implantation*
;
Cochlear Implants*
;
Combined Modality Therapy*
;
Drug Therapy
;
Electrodes
;
Hearing Loss*
;
Hearing Tests
;
Hearing*
;
Humans
;
Neuroblastoma*
;
Peripheral Blood Stem Cell Transplantation
;
Radiotherapy
;
Survival Rate